AG NCA805Alternative Names: AG-NCA805
Latest Information Update: 20 Sep 2016
At a glance
- Originator Ahn-Gook Pharmaceutical
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 30 Aug 2016 Discontinued for Asthma in South Korea (unspecified route)